D J Spalton1, G M Verdon Roe, G R Hughes
1Department of Medical Ophthalmology, St. Thomas' Hospital, London, UK.
Hydroxychloroquine retinopathy is unlikely at doses under 6.5 mg/kg with less than 10 years of treatment. Current screening guidelines for antimalarial therapy may be too rigorous, with visual field testing offering limited benefit.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: